Repetitive transcranial magnetic stimulation over the orbitofrontal cortex for obsessive-compulsive disorder: a double-blind, crossover study
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
This pilot study was designed to assess the efficacy of low-frequency repetitive transcranial magnetic stimulation (rTMS) over the right orbitofrontal cortex (OFC) by means of a double-cone coil in patients suffering from obsessive-compulsive disorder. We hypothesized that low-frequency stimulation of the OFC would lead to a reduction in clinical symptoms, as measured on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). A randomized, double-blind, crossover design was implemented with two 1-week treatment periods (active stimulation versus sham stimulation) separated by a 1-month washout period. Concomitantly, a subgroup of patients underwent a positron emission tomography (PET) scan after each stimulation sequence. Statistical analyses compared the Y-BOCS scores at the end of each period. At day 7, we observed a significant decrease from baseline in the Y-BOCS scores, after both active (P<0.01) and sham stimulation (P=0.02). This decrease tended to be larger after active stimulation than after sham stimulation: −6 (−29, 0) points versus −2 (−20, 4) points (P=0.07). Active versus sham PET scan contrasts showed that stimulation was related to a bilateral decrease in the metabolism of the OFC. The OFC should definitely be regarded as a key neuroanatomical target for rTMS, as it is easier to reach than either the striatum or the subthalamic nucleus, structures favored in neurosurgical approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
Power failure: why small sample size undermines the reliability of neuroscience
Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & Munafò, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3475 · Cited by 7,641
A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data
Eickhoff, S. B., Stephan, K. E., Mohlberg, H., Grefkes, C., Fink, G. R., Amunts, K., & Zilles, K. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.12.034 · Cited by 4,033
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
Neurobiology of emotion perception I: the neural basis of normal emotion perception
Phillips, M. L., Drevets, W. C., Rauch, S. L., & Lane, R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00168-9 · Cited by 2,173
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder
Mallet, L., Polosan, M., Jaafari, N., Baup, N., Welter, M.-L., Fontaine, D., Montcel, S. T. D., Yelnik, J., Chéreau, I., Arbus, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708514 · Cited by 965
Self-citationPathophysiology of obsessive–compulsive disorder
Aouizerate, B., Guehl, D., Cuny, E., Rougier, A., Bioulac, B., Tignol, J., & Burbaud, P. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.02.004 · Cited by 341
Nakao, T., Nakagawa, A., Yoshiura, T., Nakatani, E., Nabeyama, M., Yoshizato, C., Kudoh, A., Tada, K., Yoshioka, K., Kawamoto, M., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.039 · Cited by 307
Mantovani, A., Simpson, H. B., Fallon, B. A., Rossi, S., & Lisanby, S. H. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990435 · Cited by 281
Research works printed but not linked: 31
- Association Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: DSM-IV-TR®. American Psychiatric Association: Washington, DC, USA, 2000.
- Nuttin BJ, Gabriels LA, Cosyns PR, Meyerson BA, Andreewitch S, Sunaert SG et al. Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery 2003; 52: 1263–1272, discussion 1272-1264. · DOI · Paper page
- Evans DW, Lewis MD, Iobst E . The role of the orbitofrontal cortex in normally developing compulsive-like behaviors and obsessive-compulsive disorder. Brain Cogn 2004; 55: 220–234. · DOI · Paper page
- Modell JG, Mountz JM, Curtis GC, Greden JF . Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 1989; 1: 27–36. · DOI
- Nordahl TE, Benkelfat C, Semple WE, Gross M, King AC, Cohen RM . Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology 1989; 2: 23–28. · DOI · Paper page
- Rubin RT, Villanueva-Meyer J, Ananth J, Trajmar PG, Mena I . Regional xenon 133 cerebral blood flow and cerebral technetium 99 m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography. Arch Gen Psychiatry 1992; 49: 695–702. · DOI · Paper page
- Millet B, Dondaine T, Reymann J-M, Bourguignon A, Naudet F, Jaafari N et al. Obsessive compulsive disorder networks: positron emission tomography and neuropsychology provide new insights. PLoS One 2013; 8: e53241. · DOI · Paper page
- Rubin RT, Ananth J, Villanueva-Meyer J, Trajmar PG, Mena I . Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biol Psychiatry 1995; 38: 429–437. · DOI
- Le Jeune F, Verin M, N'Diaye K, Drapier D, Leray E, Du Montcel ST et al. Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry 2010; 68: 1016–1022. · DOI · Paper page
- Haynes WI, Mallet L . High-frequency stimulation of deep brain structures in obsessive-compulsive disorder: the search for a valid circuit. Eur J Neurosci 2010; 32: 1118–1127. · DOI · Paper page
- Gershon AA, Dannon PN, Grunhaus L . Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry 2003; 160: 835–845. · DOI · Paper page
- Deng ZD, Lisanby SH, Peterchev AV . Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs. Brain Stimul 2013; 6: 1–13. · DOI · Paper page
- Klein E, Kreinin I, Chistyakov A, Koren D, Mecz L, Marmur S et al. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry 1999; 56: 315–320. · DOI · Paper page
- Pizzagalli DA, Nitschke JB, Oakes TR, Hendrick AM, Horras KA, Larson CL et al. Brain electrical tomography in depression: the importance of symptom severity, anxiety, and melancholic features. Biol Psychiatry 2002; 52: 73–85. · DOI · Paper page
- Alonso P, Pujol J, Cardoner N, Benlloch L, Deus J, Menchon JM et al. Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2001; 158: 1143–1145. · DOI · Paper page
- Greenberg BD, George MS, Martin JD, Benjamin J, Schlaepfer TE, Altemus M et al. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry 1997; 154: 867–869. · DOI · Paper page
- Prasko J, Paskova B, Zalesky R, Novak T, Kopecek M, Bares M et al. The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study. Neuro Endocrinol Lett 2006; 27: 327–332.
- Sachdev PS, Loo CK, Mitchell PB, McFarquhar TF, Malhi GS . Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation. Psychol Med 2007; 37: 1645–1649. · DOI · Paper page
- Mantovani A, Lisanby SH, Pieraccini F, Ulivelli M, Castrogiovanni P, Rossi S . Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). Int J Neuropsychopharmacol 2006; 9: 95–100. · DOI · Paper page
- Jaafari N, Rachid F, Rotge JY, Polosan M, El-Hage W, Belin D et al. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder: a review. World J Biol Psychiatry 2012; 13: 164–177. · DOI · Paper page
- Gomes PV, Brasil-Neto JP, Allam N . Rodrigues de Souza E. A randomized, double-blind trial of repetitive transcranial magnetic stimulation in obsessive-compulsive disorder with three-month follow-up. J Neuropsychiatry Clin Neurosci 2012; 24: 437–443. · DOI · Paper page
- Ruffini C, Locatelli M, Lucca A, Benedetti F, Insacco C, Smeraldi E . Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation. Prim Care Companion J Clin Psychiatry 2009; 11: 226–230. · DOI · Paper page
- Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22–33, quiz 34-57.
- Montgomery SA, Asberg M . A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–389. · DOI · Paper page
- Friston K, Holmes A, Worsly K, Poline J, Frith C, Frackowiak RS . Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995; 2: 189–210. · DOI · Paper page
- Talairach. J, Tournoux. P (eds) Co-planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System – an Approach to Cerebral Imaging. Thieme Medical Publishers: New York, NY, USA, 1988.
- Mansur CG, Myczkowki ML, de Barros Cabral S, Sartorelli Mdo C, Bellini BB, Dias AM et al. Placebo effect after prefrontal magnetic stimulation in the treatment of resistant obsessive-compulsive disorder: a randomized controlled trial. Int J Neuropsychopharmacol 2011; 14: 1389–1397. · DOI · Paper page
- Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET . Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev 2008; 32: 525–549. · DOI · Paper page
- Friedlander L, Desrocher M . Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clin Psychol Rev 2006; 26: 32–49. · DOI · Paper page
- Stein DJ . Neurobiology of the obsessive-compulsive spectrum disorders. Biol Psychiatry 2000; 47: 296–304. · DOI · Paper page
- Schilman EA, Klavir O, Winter C, Sohr R, Joel D . The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system. Neuropsychopharmacology 2010; 35: 1026–1039. · DOI
Cited by
Lefaucheur, J.-P., Aleman, A., Baeken, C., Benninger, D. H., Brunelin, J., Di Lazzaro, V., Filipović, S. R., Grefkes, C., Hasan, A., Hummel, F. C., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.002 · Cited by 2,382
Rossi, S., Antal, A., Bestmann, S., Bikson, M., Brewer, C., Brockmöller, J., Carpenter, L. L., Cincotta, M., Chen, R., Daskalakis, J. D., et al. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.10.003 · Cited by 1,573
Carmi, L., Tendler, A., Bystritsky, A., Hollander, E., Blumberger, D. M., Daskalakis, J., Ward, H., Lapidus, K., Goodman, W., Casuto, L., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101180 · Cited by 458
McTeague, L. M., Rosenberg, B. M., Lopez, J. W., Carreon, D. M., Huemer, J., Jiang, Y., Chick, C. F., Eickhoff, S. B., & Etkin, A. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18111271 · Cited by 388
Fettes, P., Schulze, L., & Downar, J. (2017) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2017.00025 · Cited by 299
Carmi, L., Alyagon, U., Barnea-Ygael, N., Zohar, J., Dar, R., & Zangen, A. (2018) · Brain Stimulation · doi:10.1016/j.brs.2017.09.004 · Cited by 264
Norman, L. J., Taylor, S. F., Liu, Y., Radua, J., Chye, Y., De Wit, S. J., Huyser, C., Karahanoglu, F. I., Luks, T., Manoach, D., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.11.010 · Cited by 189
“Moreover, treatment with cognitive behavioral therapy (57), antidepressants (58) and repetitive transcranial magnetic stimulation (59) modulates aLPFC cortex activity in OCD, and targeting this region with neurofeedback training decreases OCD symptoms (60, 61).”
BackgroundFineberg, N. A., Hollander, E., Pallanti, S., Walitza, S., Grünblatt, E., Dell’Osso, B. M., Albert, U., Geller, D. A., Brakoulias, V., Janardhan Reddy, Y. C., et al. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000314 · Cited by 161
Rehn, S., Eslick, G. D., & Brakoulias, V. (2018) · Psychiatric Quarterly · doi:10.1007/s11126-018-9566-7 · Cited by 142
“However, the number of RCTs focusing on the SMA [31, 38] and OFC [33] is increasing.”
Feffer, K., Fettes, P., Giacobbe, P., Daskalakis, Z. J., Blumberger, D. M., & Downar, J. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.11.011 · Cited by 116
Obsessive-compulsive disorder: Etiology, neuropathology, and cognitive dysfunction
Jalal, B., Chamberlain, S. R., & Sahakian, B. J. (2023) · Brain and Behavior · doi:10.1002/brb3.3000 · Cited by 111
“Follow-upPETscancontrasts showed that active stimulation was linked to a bilateral decrease in the metabolism of the OFC, stressing the role of the OFC in OCD (Nauczyciel et al., 2014).”
BackgroundZhou, D.-D., Wang, W., Wang, G.-M., Li, D.-Q., & Kuang, L. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.033 · Cited by 106
Lusicic, A., Schruers, K. R., Pallanti, S., & Castle, D. J. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s121140 · Cited by 81
Senço, N. M., Huang, Y., D’Urso, G., Parra, L. C., Bikson, M., Mantovani, A., Shavitt, R. G., Hoexter, M. Q., Miguel, E. C., & Brunoni, A. R. (2015) · Expert Review of Medical Devices · doi:10.1586/17434440.2015.1037832 · Cited by 67
Perera, M. P. N., Mallawaarachchi, S., Miljevic, A., Bailey, N. W., Herring, S. E., & Fitzgerald, P. B. (2021) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.03.010 · Cited by 51
From bed to bench side: Reverse translation to optimize neuromodulation for mood disorders
Rudebeck, P. H., Rich, E. L., & Mayberg, H. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902287116 · Cited by 42
Neuromodulation of OCD: a review of invasive and non-invasive methods
Kammen, A., Cavaleri, J., Lam, J., Frank, A. C., Mason, X., Choi, W., Penn, M., Brasfield, K., Van Noppen, B., Murray, S. B., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.909264 · Cited by 38
“Indeed, patients with OCD show reduced task-based reward learning, correlated with reduced activity in, and connectivity between, limbic structures such as the NAcc, ventral putamen, vmPFC, OFC, hippocampus, and amygdala (15, 24–27).”
BackgroundInfluentialFettes, P., Peters, S., Giacobbe, P., Blumberger, D. M., & Downar, J. (2017) · Brain Stimulation · doi:10.1016/j.brs.2016.11.008 · Cited by 31
Orbitofrontal cortex: a ‘non-rewarding’ new treatment target in depression?
Downar, J. (2019) · Current Biology · doi:10.1016/j.cub.2018.11.057 · Cited by 31
Metadata
- Authors
- Nauczyciel, C., Le Jeune, F., Naudet, F., Douabin, S., Esquevin, A., Vérin, M., Dondaine, T., Robert, G., Drapier, D., & Millet, B.
- Venue
- Translational Psychiatry
- Published
- 2014-09-09
- Volume
- 4
- Issue
- 9
- Pages
- e436-e436
- ISSN
- 2158-3188 (ISSN-L)
- OpenAlex
- W1992039739
- Cited by
- 142
- References
- 9
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/3.0/ (tdm)
- creativecommons.org/licenses/by/3.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.